Improving the stratification of intermediate risk prostate cancer-Reference-Cited by-同舟云学术

Improving the stratification of intermediate risk prostate cancer

Published:2022-09 Issue:5 Volume:74 Page:
ISSN:2724-6051
Container-title:Minerva Urology and Nephrology
language:
Short-container-title:Minerva Urol Nephrol

Author:

NOCERA Luigi,COLLÀ RUVOLO Claudia,STOLZENBACH Lara F.,DEUKER Marina,TIAN Zhe,GANDAGLIA Giorgio,FOSSATI Nicola,ABDOLLAH Firas,SUARDI Nazareno,MIRONE Vincenzo,GRAEFEN Markus,CHUN Felix K.,SAAD Fred,MONTORSI Francesco,BRIGANTI Alberto,KARAKIEWICZ Pierre I.

Publisher

Edizioni Minerva Medica

Subject

Urology,Nephrology

Link

https://www.minervamedica.it/pdf.php?cod=R19Y2022N05A0590

Reference26 articles.

1. Contemporary national trends in prostate cancer risk profile at diagnosis

2. Contemporary Evaluation of the National Comprehensive Cancer Network Prostate Cancer Risk Classification System

3. Favorable vs Unfavorable Intermediate-Risk Prostate Cancer: A Review of the New Classification System and Its Impact on Treatment Recommendations;Serrano NA;Oncology (Williston Park),2016

4. Variability in Outcomes for Patients with Intermediate-risk Prostate Cancer (Gleason Score 7, International Society of Urological Pathology Gleason Group 2–3) and Implications for Risk Stratification: A Systematic Review

5. Intermediate-risk Prostate Cancer: Stratification and Management

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Urinary PSA-ZINC biomarker outperforms standard of care in early detection of prostate cancer;Minerva Urology and Nephrology;2024-06

2. Genomic tests for persistence PSA after radical prostatectomy: smoke and mirrors or new effective tools for the clinical decision-making?;Minerva Urology and Nephrology;2023-12

3. Statins may increase the risk of being diagnosed with prostate cancer;Minerva Urology and Nephrology;2023-10

4. Artificial intelligence evaluation of confocal microscope prostate images: our preliminary experience;Minerva Urology and Nephrology;2023-09

5. Urinary outcomes of new ultra-minimally invasive treatments for prostate cancers;Current Opinion in Urology;2023-08-22